With the initial presentation of nodules, a clinician must rule out infectious disorders including various bacterial, viral, and parasitic infections. Other vasoocclusive disorders such as ...

The presentation, which was complicated by a type 2 lepra reaction (erythema nodosum leprosum), involved erythematous nodules, hypopigmented lesions ... also increased echogenicity and thickness in ...

The subcutaneous formulation of Opdivo provides a convenient alternative to intravenous administration for patients with solid tumors, maintaining efficacy and safety. The CHECKMATE-67T trial ...

Lung involvement was seen in 95% of patients, skin involvement other than erythema nodosum in 16%, extrathoracic lymph node involvement in 15%, eye involvement in 11.8%, and liver involvement in ...

The FDA approved subcutaneous Opdivo for solid tumors, providing a more convenient treatment option that reduces time toxicity and enhances patient accessibility. Subcutaneous administration allows ...